Paramus, NJ, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Catalogic Software a provider of secure data protection solutions for over 25 years, today announced Catalogic DPX 4.14, the latest version of its all-in ...
Study Results Position Company to Target Segments of $270B+ Multi-Billion Dollar Drug Delivery Systems Market 1 VANCOUVER, BC, Oct. 31, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (BVAXF) ...
VANCOUVER, BC, Jan. 16, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights the potential for its DPX™ non-systemic immune ...
Based on promising results, the biotech IMV has moved into phase 2b trials with a cancer vaccine composed of survivin epitopes that uses the company’s proprietary delivery system to elicit persistent ...
TipRanks on MSN
BioVaxys sharpens DPX vaccine strategy with new leadership and positive breast cancer data
BioVaxys Technology ( ($TSE:BIOV) ) just unveiled an announcement. BioVaxys’ 2025 corporate review highlights the integration of the DPX platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results